Intellectual Property

Obtaining a patent is a crucial step to safeguard the intellectual property of a novel biomedical intervention and to raise funding for its development. This course discusses the pros and cons of intellectual property and the do’s and don’ts to protect your biomedical invention in a timely manner.

Blended learning

Stay updated about this course

What makes this course special?

This course does not deal with intellectual property rights such as trademarks, copyrights or  design rights but we focus here on patent rights. Other IP rights can be useful to protect a biomedical invention, for example, obtaining design rights as part of the design of a medical device. However, patents are the most common and generally offers the most extensive protection for a biomedical invention. To practice the principles, several case studies that are based on real-world biomedical inventions are included. These cases range from simplistic to extensive to illustrate the complexity and the dynamics involved in patents in this field.

What will you learn?

In 5 weeks, you are introduced to the world of IP for new medical interventions. You will learn the value of a patent (and its limitations) for biomedical research and how to take these into account for a world-wide patent strategy. A world-wide strategy includes obtaining multiple patents and creating a patent portfolio for your invention. It is essential to properly maintain a patent portfolio and to design a strategy well before obtaining your patent. Finally, our experts share with you some trade secrets at different stages in the lifetime of your patent. Upon completion of this online course, you will have a clear understanding of the basic principles and the do’s and don’ts to protect your biomedical invention in a timely manner.

5 things you will take away from this course

  1. perform patent searches in the public patent data bases, including the analysis of a patent’s legal status.
  2. identify different patenting routes, including cost estimates, and develop a cost-effective patenting strategy.
  3. understand the principles behind designing a patent portfolio.
  4. understand the principles of patent enforcement procedures.
  5. Understand the principles behind commercialization of patents as a tool to exploit intellectual property.

Program information

Course length5 weeks

Study load5 hours a week

Your teacher

Kees Recourt

Requirements

  • at least a master's degree in a subject related to (bio)medical science
  • a few years of relevant working experience.
  • no prior knowledge or experience with intellectual property is required for this course.

Intellectual Property contributors

Intellectual Property Online

Bruno Vandermeulen

IP Lawyer - Member of the Brussels Bar


Independent IP practitioner

On-campus

Intellectual Property Online

Nacer Lounis

Senior Principal Scientist


Janssen Pharmaceutica

On-campus

Intellectual Property Online

Tine de Marez

Senior Director, Compound Development Team Leader TB


Johnson & Johnson

Intellectual Property Online

Bert Leufkens

Professor of Pharmaceutical Policy and Regulatory Science and Former Chair of Medicines Evaluation Board


Utrecht Institute for Pharmaceutical Sciences (UIPS)

Intellectual Property Online

Henk Schuring

VP-Head Rare Nephrology


Sanofi Genzyme

Intellectual Property Online

Sjaak Bot

VP, Head of EMEA Regulatory Affairs


Janssen

Intellectual Property Online

Bernd van der Meulen

Professor of Comparative Food Law


European Institute for Food Law / Renmin University of China Law School

Intellectual Property Online

Frank Landolt

V.P. intellectual property and legal


Ablynx N.V.

On-campus

Intellectual Property Online

Erik Niks

Neurologist - Pediatric neurologist


Leiden University Medical Center

On-campus

Intellectual Property Online

Piet Hinoul

Global Head, Pre-Clinical, Clinical and Medical Affairs


J&J Ethicon

On-campus

Intellectual Property Online

Ad Sitsen

Owner


ClinPharMed Consultancy for Drug Development

Intellectual Property Online

Eline Bunnik

Assistant professor Medical Ethics and Philosophy of Medicine


Erasmus MC

Intellectual Property Online

Maurits Westerik

Senior Counsel


Bird & Bird

Intellectual Property Online

Andrea Kamage

Patent Group Leader


Johnson & Johnson

Intellectual Property Online

Bart Swinkels

Partner


NLO

Intellectual Property Online

Karin Verzijden

Food and Pharma Lawyer


Axon Lawyers

On-campus

Intellectual Property Online

Ineke Jonker-Hoogerkamp

Consultant Regulatory Affairs and Drug Development


Paul Janssen Futurelab & Eagle Pharma Consult

Intellectual Property Online

Kees Recourt

Investment Manager


Mibiton Foundation

Intellectual Property Online

Paul Stoffels

Chief scientific officer


Johnson & Johnson

Intellectual Property Online

Tom Huizinga

Head of the Department of Rheumatology


Leiden University Medical Centre

On-campus

Intellectual Property Online

Marcel Kenter

Director


Paul Janssen Futurelab Leiden

On-campus

Intellectual Property Online

Koen Andries

VP Scientific Fellow Infectious Diseases Discovery


Janssen Pharmaceutica NV

On-campus

Intellectual Property Online

Andreas Wallnöfer

General Partner


BioMed Partners Venture Capital (former Head of Clinical Research & Exploratory Development at F. Hoffmann-La Roche Ltd.)

On-campus

Intellectual Property Online

Justin Hay

Pharmacokinetics Assessor


Medicines and Healthcare products Regulatory Agency

On-campus

Intellectual Property Online

André Elferink

Clinical epidemiologist


Dutch Medicines Evaluation Board

On-campus

Intellectual Property Online

Rob Zuiker

Senior Clinical Scientist


CHDR

On-campus

Intellectual Property Online

Barbara J. van Zwieten-Boot

Vice Chair


Medicines Evaluation Board, The Netherlands

Intellectual Property Online

Hans-Georg Eichler

Senior Medical Officer


European Medicines Agency

On-campus

Intellectual Property Online

Robert Klautz

Thoracic Surgeon


Leiden University Medical Centre

On-campus

Intellectual Property Online

Matthijs Moerland

Research Director Translational Biomarkers


CHDR

Intellectual Property Online

Joris Rotmans, MD, PhD

internist-nephrologist


LUMC

On-campus

Intellectual Property Online

Janneke Meulenberg

CEO


Arthrogen

Intellectual Property Online

Inge de Lepeleire

Director Translational Pharmacology


MSD Europe

On-campus

Intellectual Property Online

Koos Burggraaf

Research Director CVS & Metabolism


CHDR

Intellectual Property Online

Johan Garssen

Director Immunology Platform


Danone/Nutricia Research

On-campus

Intellectual Property Online

Ingrid de Visser

Senior Clinical Scientist


CHDR

Intellectual Property Online

Rick Kuntz

Senior Vice President and Chief Scientific, Clinical and Regulatory Officer


Medtronic

On-campus

Intellectual Property Online

Geert Jan Groeneveld

Research Director CNS


CHDR

Intellectual Property Online

Oliver Bisazza

Director Regulatory Policy


Medtronic

Intellectual Property Online

Saco de Visser

Teacher and Clinical Pharmacologist


Paul Janssen Futurelab Leiden

On-campus

Intellectual Property Online

Adam Cohen

CEO and clinical pharmacologist


Centre for Human Drug Research

Intellectual Property Online

Richard Shull

Head of Deal Structuring and Trading Fundamentals


Shell

Intellectual Property Online

Pierre Peeters

Former site head early stage development


Organon

Stay updated about this course